Journal
BLOOD
Volume 118, Issue 14, Pages 3879-3889Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2011-04-349761
Keywords
-
Categories
Funding
- National Institutes of Health [CA128913, AI059718, AI073587, AR059010]
- The Netherlands Organization for Scientific Research [916.046.014]
- National Cancer Institute [P30CA16672]
- National Research Service Award [T32DC007367]
- National Institutes of Health at University of Texas M. D. Anderson Cancer Center [T32-CA-09598-16]
Ask authors/readers for more resources
Plasmacytoid dendritic cells (pDCs) reside in bone marrrow and lymphoid organs in homeostatic conditions and typically secrete abundant quantities of type I interferons (IFNs) on Toll-like receptor triggering. Recently, a pDC population was identified within Peyer patches (PPs) of the gut that is distinguished by its lack of IFN production; however, the relationship of PP pDCs to pDCs in other organs has been unclear. We report that PP pDCs are derived from common DC progenitors and accumulate in response to Fms-like tyrosine kinase 3 ligand, yet appear divergent in transcription factor profile and surface marker phenotype, including reduced E2-2 and CCR9 expression. Type I IFN signaling via STAT1 has a cell-autonomous role in accrual of PP pDCs in vivo. Moreover, IFN-alpha enhances pDC generation from DC progenitors by a STAT1-dependent mechanism. pDCs that have been developed in the presence of IFN-alpha resemble PP pDCs, produce inflammatory cytokines, stimulate Th17 cell generation, and fail to secrete IFN-alpha on Toll-like receptor engagement. These results indicate that IFN-alpha influences the development and function of pDCs by inducing emergence of an inflammatory (Th17-inducing) antigen-presenting subset, and simultaneously regulating accumulation of pDCs in the intestinal microenvironment. (Blood. 2011;118(14):3879-3889)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available